Join the Systemic Mastocytosis group to help and get support from people like you.
Systemic Mastocytosis News
Related terms: Mastocytosis, Systemic, Systemic Mast Cell Disease
FDA Approves Ayvakit (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis
CAMBRIDGE, Mass., May 22, 2023 /PRNewswire/ – Blueprint Medicines Corporation (Nasdaq: BPMC) today announced that the U.S. Food and Drug Administration (FDA) has approved Ayvakit® (avapritinib) for ...
FDA Approves Blueprint Medicines' Ayvakit (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis
First precision therapy that specifically targets the primary driver of the disease Durable clinical responses, including complete remissions, shown in patients with or without prior treatment Full...
FDA Approves Rydapt (midostaurin) for FLT3-Mutated Acute Myeloid Leukemia and Systemic Mastocytosis
April 28, 2017 – The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific...
Ask a question
To post your own question to this support group, sign in or create an account.